Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 30, 2024Journal of Student ResearchOpen Access

Epigenetic Modifications: A Therapeutic Approach in Alzheimer's Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

PSP SanthoshDVDr.Jobin VarkeyVTVirgel Torremocha

Discussion

Loading...

Member takes

Overview

Observational analysis discusses epigenetic therapies for reversing cognitive deficits in Alzheimer's patients, suggesting a novel treatment pathway.

Key Points

  • Epigenetic therapies show promise in reversing cognitive deficits associated with Alzheimer's disease, and this could change treatment approaches.
  • In pre-clinical trials, treatments involving DNA methylation inhibitors and histone deacetylase inhibitors demonstrated potential in reversing Alzheimer's pathology.
  • This review assesses existing literature on epigenetic modifications related to Alzheimer's disease, highlighting significant findings from multiple studies.
  • Further research and clinical trials may enable the transition of epigenetic therapies into standard Alzheimer's treatments, addressing the underlying pathology.

Cite This Study

Santhosh et al. (2024) studied this question.

synapsesocial.com/papers/68af6595ad7bf08b1eae5642https://doi.org/10.47611/jsrhs.v13i4.7924
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Targeting epigenetic mechanisms in amyloid-β–mediated Alzheimer’s pathophysiology: unveiling therapeutic potential2024 · 1 citations
  2. 2Epigenetics in Alzheimer’s Disease: A Critical Overview2024 · 17 citations
  3. 3Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents2024 · 18 citations
  4. 4A comprehensive study on epigenetic biomarkers in early detection and prognosis of Alzheimer's disease2024 · 17 citations
  5. 5Epigenetic modulations and nutrient interactions in Alzheimer's disease: unveiling potential therapeutic pathways2025